Marine Drugs · 2017 · 107 citations · 31 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyLung CancerMarine Bioactive CompoundsMarine Drug DiscoveryMarine Natural ProductsMarine PharmacologyOncology PharmacologyAnticancer ActivityAnticancer Marine CompoundsAnticancer Mechanism Of ActionMarine-derived Anticancer CompoundsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment
Lung cancer is the leading cause of cancer mortality worldwide and non-small-cell lung cancer (NSCLC) is the most common type. Marine plants provide rich resources for anticancer drug discovery. Fucoxanthin (FX), a Laminaria japonica extract, has attracted great research interest for its antitumor activities. Accumulating evidence suggests anti-proliferative effects of FX on many cancer cell lines including NSCLCs, but the detailed mechanisms remain unclear. In the present investigation, we confirmed molecular mechanisms and in vivo anti-lung cancer effect of FX at the first time. Flow cytometry, real-time PCR, western blotting and immunohistochemistry revealed that FX arrested cell cycle and induced apoptosis by modulating expression of p53, p21, Fas, PUMA, Bcl-2 and caspase-3/8. These results show that FX is a potent marine drug for human non-small-cell lung cancer treatment.
31
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Honglin Li, Hong Zhu, Chi-jie Xu et al. · Cell · 1998 · 4.4K citations · Full text
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Katsunori Nakano, Karen H. Vousden · Molecular Cell · 2001 · 2.3K citations · Full text